Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Grid Computing Harnessed for Childhood Cancer Research

An international consortium is seeking crowdsourced computing power to screen drug candidates for treating a number of cancers affecting children. . . . → Read More: Grid Computing Harnessed for Childhood Cancer Research

Pharma Firms Start Non-Communicable Disease Initiative

A group of 22 pharmaceutical companies is supporting worldwide projects to improve access to prevention and treatments for chronic disorders like cancer and heart disease, in lower-resource regions. . . . → Read More: Pharma Firms Start Non-Communicable Disease Initiative

Precision Health Tech Network Expands, Invests $400M

Digital Life Alliance, a consortium of enterprises applying advanced technologies to health and medicine that plans to offer personalized solutions, is expanding to 7 members, as well as iCarbonX, the company that founded the network. . . . → Read More: Precision Health Tech Network Expands, Invests $400M

Biotech, Pharma Partner on Neuro Drug Discovery

A collaboration between a biotechnology enterprise tracking defective proteins and pharmaceutical company plans to discover new treatments for neurodegenerative disorders. . . . → Read More: Biotech, Pharma Partner on Neuro Drug Discovery

Ostrich Antibodies to Fight Resistant Infections

A biotechnology company developing antibodies grown in ostrich eggs is partnering with a Boston hospital to test a new treatment for Clostridium difficile, or C. difficile, a stubborn infection, increasingly resistant to antibiotics, and often contracted in hospitals. . . . → Read More: Ostrich Antibodies to Fight Resistant Infections

Liquid Biopsy Lab to Reside at Cancer Institute

A designer of liquid biopsy tests to diagnose cancer is establishing a lab to study circulating tumor cells at John Wayne Cancer Institute in Santa Monica, California. . . . → Read More: Liquid Biopsy Lab to Reside at Cancer Institute

Teva Licenses Pain Relief Antibody for $1.25 Billion

Teva Pharmaceutical Industries is licensing from biotechnology company Regeneron Pharmaceuticals an engineered antibody that targets proteins supporting pain signals. . . . → Read More: Teva Licenses Pain Relief Antibody for $1.25 Billion

Takeda Awarded $19.8 Million for Zika Vaccine

Takeda Pharmaceutical Company is receiving $19.8 million from a U.S. public health agency for initial steps to develop a vaccine to prevent Zika infections. . . . → Read More: Takeda Awarded $19.8 Million for Zika Vaccine

$1 Million Challenge Seeks Child Health Solutions

A new challenge seeks technologies and solutions to reduce child mortality and improve the health of children in low-resource regions of the world. . . . → Read More: $1 Million Challenge Seeks Child Health Solutions

Trial Shows Fertility Treatment Boosts IVF Pregnancy Rate

(Greyerbaby, Pixabay)

11 August 2015. A clinical study of cellular treatments for women using in-vitro fertilization shows the treatments increased pregnancy rates compared to women receiving standard IVF alone. Findings from the study that tested treatments developed by IVF technology company OvaScience Inc. in Cambridge, Massachusetts are scheduled to be published on 25 August . . . → Read More: Trial Shows Fertility Treatment Boosts IVF Pregnancy Rate